Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment
Elizabeth J. Shaughnessy, Abde M. Abukhdeir, Thomas R. Battersby, Bowen Cui, Simon P. Dearden, Lindee Goh, Janet Y. Jin, Alexander G. Kohlmann, Kelly S. Oliner, Scott D. Patterson, Danielle M. Townsley, Sophie E. Wildsmith, Barbara A. Zehnbauer npj Precision Oncology
· Springer Nature
· 2026-11-18
· DOI: 10.1038/s41698-026-01765-8
Abstract
npj Precision Oncology, Published online: 18 November 2026; doi:10.1038/s41698-026-01765-8 Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment
Elizabeth J. Shaughnessy, Abde M. Abukhdeir, Thomas R. Battersby, Bowen Cui, Simon P. Dearden, Lindee Goh et al. Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment. // npj Precision Oncology. – 2026. – DOI: 10.1038/s41698-026-01765-8. – URL: https://www.nature.com/articles/s41698-026-01765-8
Elizabeth J. Shaughnessy, Abde M. Abukhdeir, Thomas R. Battersby, Bowen Cui, Simon P. Dearden, Lindee Goh, Janet Y. Jin, Alexander G. Kohlmann, Kelly S. Oliner, Scott D. Patterson, Danielle M. Townsley, Sophie E. Wildsmith, & Barbara A. Zehnbauer (2026). Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01765-8
Elizabeth J. Shaughnessy, et al. “Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment.” npj Precision Oncology, 2026. doi:10.1038/s41698-026-01765-8.
@article{Shaughnessy2026,
title = {Accelerating access to precision oncology trials: risk-benefit framework for local biomarker tests for patient enrollment},
author = {Shaughnessy, Elizabeth J. and Abukhdeir, Abde M. and Battersby, Thomas R. and Cui, Bowen and Dearden, Simon P. and Goh, Lindee and Jin, Janet Y. and Kohlmann, Alexander G. and Oliner, Kelly S. and Patterson, Scott D. and Townsley, Danielle M. and Wildsmith, Sophie E. and Zehnbauer, Barbara A.},
journal = {npj Precision Oncology},
year = {2026},
doi = {10.1038/s41698-026-01765-8},
url = {https://www.nature.com/articles/s41698-026-01765-8}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment